Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Gastroenterology|April 13, 2017
EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of PatientsSriram Srivatsa, Mariel C Paul, Claudia Cardone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal CancerStefania Napolitano, Melanie Woods, Hey Min Lee, et al.
JAMA Network Open|April 9, 2024
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled TrialDavide Ciardiello, Erika Martinelli, Teresa Troiani, et al.
The Oncologist|September 8, 2018
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN StudyEric Van Cutsem, Erika Martinelli, Stefano Cascinu, et al.
Biomedicines|April 27, 2024
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung CancerCaterina De Rosa, Francesca Iommelli, Viviana De Rosa, et al.
Journal of Translational Medicine|November 24, 2022
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLCCarminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, et al.
International Journal of Cancer|July 1, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trialStefania Napolitano, Davide Ciardiello, Vincenzo De Falco, et al.
ESC Heart Failure|April 1, 2022
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patientsAlessandra Cuomo, Valentina Mercurio, Gilda Varricchi, et al.
Medical Oncology (Northwood, London, England)|February 11, 2021
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotypeDavide Ciardiello, Bernadette Blauensteiner, Nunzia Matrone, et al.
The Oncologist|July 11, 2022
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY StudyGiulia Mentrasti, Luca Cantini, Clizia Zichi, et al.
Pageof 17